Xtalks Life Science Webinars
This webinar will introduce key SDD development considerations for identifying a stable formulation that enhances and sustains in-vivo drug solubility.
TORONTO (PRWEB)
August 13, 2020
Join Dr. Sami Karaborni, Co-Founder, IHP Therapeutics and Dr. Santipharp Panmai, Executive Director, Formulation R&D, STA Pharmaceutical, a WuXi AppTec company (WuXi STA) in a live webinar on Wednesday, September 2, 2020 at 11am EDT (4pm BST/UK).
Low oral bioavailability of poorly water-soluble drug candidates is currently one of the top challenges for drug development. Among enabling technologies available today, there is no “one size fits all” solution. In this webinar, industry experts will discuss the pros and cons of different drug delivery technologies and strategies for selecting the most suitable technology for any given molecule.
Spray-dried dispersion (SDD) has been successfully applied to many drug products in recent years. This webinar will introduce key SDD development considerations for identifying a stable formulation that enhances and sustains in-vivo drug solubility.
For more information or to register for this event, visit Practical Considerations for Selecting Bioavailability-Enhancing Technologies.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks, visit http://xtalks.com.
For information about hosting a webinar, visit http://xtalks.com/why-host-a-webinar/.
Contact:
Sydney Perelmutter
Tel: +1 (416) 977-6555 x 352
Email: sperelmutter@xtalks.com
Share article on social media or email: